
Loading, please wait...

Loading, please wait...

The NII PhD Admissions 2026 for the Monsoon Session are now open for aspiring researchers. Consequently, the National Institute of Immunology (NII) invites applications from candidates passionate about life sciences. This program offers unique opportunities in various interdisciplinary fields. Therefore, medical and science graduates should consider this prestigious research pathway.
Students can explore domains such as immunology and infectious disease biology. Additionally, the curriculum covers molecular and cellular biology, chemical biology, and computational biology. These areas focus on advancing biological research across multiple domains. Furthermore, the institute provides a robust environment for structural and chronic disease biology studies.
Applicants must hold a Master’s degree or a 4-year B.Sc./B.Tech. degree. Moreover, M.V.Sc. or MBBS graduates recognized by the Regional Center for Biotechnology are eligible. Candidates need at least 60% aggregate marks in their qualifying exams. However, a 5% relaxation applies to OBC NCL, SC, ST, PwD, and EWS categories. Crucially, a valid 5-year research fellowship from UGC, CSIR, ICMR, or DBT is mandatory.
The selection involves a rigorous offline interview conducted at the New Delhi campus. NII will notify the shortlisted candidates on May 11, 2026. Subsequently, the interviews will take place from June 8 to June 12, 2026. Outstation candidates may receive one-day accommodation at minimal charges. Finally, the program officially commences on July 6, 2026.
Q1: What is the application deadline for the program?
Candidates must submit their online applications between April 10 and April 30, 2026.
Q2: Is a fellowship mandatory for admission?
Yes, applicants must possess a valid 5-year research fellowship from a government-recognized body like CSIR or DBT.
Q3: Where will the PhD interviews take place?
The selection committee will conduct offline interviews at the BRIC-NII campus in New Delhi.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


NII invites applications for its Monsoon Session 2026 PhD program. Eligible MBBS and science graduates can apply by April 30, 2026. Join top-tier research....
6 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today